Tuberculosis News and Research

Latest Tuberculosis News and Research

New study reveals turmeric and Tinospora Cordifolia reduce liver injury risk in TB patients

The effectiveness of herbs and alternative medicines in preventing liver injury induced by anti-tuberculosis (anti-TB) drugs.

16 Nov 2023

Do Republican spending cuts threaten federal HIV funding? For some programs, yes.

Republicans in Congress are "trying to wipe out federal funding to end the HIV epidemic."

14 Nov 2023

Discovery of two new enzymes offers easier ways to study and manufacture complex natural chemicals

Slumbering among thousands of bacterial strains in a collection of natural specimens at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, several fragile vials held something unexpected, and possibly very useful.

13 Nov 2023

New hope for TB patients as UNITE4TB launches clinical trial program

Today, UNITE4TB, an international public-private partnership striving to fast-track the development of innovative Tuberculosis (TB) treatments, announced the start of its phase 2B/C clinical trial program with the first participant enrolled at its trial site in Cape Town, South Africa.

13 Nov 2023

Charting the future of IBD treatment: From immune modulators to microRNA therapies

In a recent study published in the journal eGastroenterology, researchers delved into the latest therapeutic strategies for managing inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease. The paper discusses emerging treatments ranging from immune-modulating drugs and biologics to novel approaches like microRNA upregulators and stem cell therapies, highlighting the need for precision medicine in IBD care.

8 Nov 2023

Fingertip blood test could aid in rapid diagnosis of tuberculosis in children

An international research consortium led by LMU has tested a rapid new analytical tool which needs just a bloodsample from the fingertip.

31 Oct 2023

Epidemic: What good is a vaccine when there is no rice?

The 1970s was the deadliest decade in the "entire history of Bangladesh," said environmental historian Iftekhar Iqbal

24 Oct 2023

University of Montana awarded $12.3 million contract to develop novel vaccine adjuvant for TB vaccine

The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for use in a tuberculosis vaccine. Adjuvants are substances that boost the effectiveness of vaccines.

24 Oct 2023

Study reveals how tuberculosis bacteria form cords to resist antibiotics

The ability of Mycobacterium tuberculosis (MTB), a serious respiratory infection, to form snake-like cords was first noted nearly 80 years ago. In a study published October 20 in the journal Cell, investigators report the biophysical mechanisms by which these cords form and demonstrate how several generations of dividing bacteria hang together to create these structures that enable resistance to antibiotics.

20 Oct 2023

Promising breakthroughs ignite hope for a novel and effective Tuberculosis vaccine

The success and challenges of developing different tuberculosis (TB) vaccine types.

17 Oct 2023

Study reveals previously unappreciated role for innate immune cells in early stages of TB infection

A new study from the University of Pittsburgh Center for Vaccine Research published today in the Journal of Experimental Medicine describes a previously unappreciated role for a class of immune cells in the early stages of tuberculosis (TB) infection.

16 Oct 2023

New TB treatments tackle the disease without wrecking your microbiome

Researchers in a study published in The Lancet Microbe examined how various tuberculosis treatment regimens affect the respiratory microbiome. They found that certain treatments control tuberculosis effectively while minimally impacting the diversity and health of the respiratory microbiome.

15 Oct 2023

Gates Foundation announces investments to advance mRNA vaccine research and manufacturing

At the 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries’ (LMICs) capacity to develop high-quality, lifesaving vaccines at scale.

14 Oct 2023

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

The research paper explores the multifaceted role of the IL-17 family in immune response, covering everything from infection control to pathological conditions like autoimmune diseases and cancer. Future therapies may exploit IL-17's unique signaling pathways to offer more targeted and cost-effective treatments.

12 Oct 2023

Tuberculosis News and Research

Latest Tuberculosis News and Research

New study reveals turmeric and Tinospora Cordifolia reduce liver injury risk in TB patients

Do Republican spending cuts threaten federal HIV funding? For some programs, yes.

Discovery of two new enzymes offers easier ways to study and manufacture complex natural chemicals

New hope for TB patients as UNITE4TB launches clinical trial program

Charting the future of IBD treatment: From immune modulators to microRNA therapies

Fingertip blood test could aid in rapid diagnosis of tuberculosis in children

Epidemic: What good is a vaccine when there is no rice?

University of Montana awarded $12.3 million contract to develop novel vaccine adjuvant for TB vaccine

Study reveals how tuberculosis bacteria form cords to resist antibiotics

Promising breakthroughs ignite hope for a novel and effective Tuberculosis vaccine

Study reveals previously unappreciated role for innate immune cells in early stages of TB infection

New TB treatments tackle the disease without wrecking your microbiome

Gates Foundation announces investments to advance mRNA vaccine research and manufacturing

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

Fighting tuberculosis: Breakthrough analysis reveals mixed strain infections

Unlocking hope: Promising treatments for cognitive impairment in HIV patients on the horizon

New TB vaccination strategy could save hundreds of thousands of lives with HIV

Epidemic: Bodies remember what was done to them

COVID-19's ripple effect: South African TB diagnostics take a hit

'Guard mechanism' discovered for protein that attacks microbes in infected cells

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Tuberculosis News and Research

Latest Tuberculosis News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in